Free Trial
LON:SENS

Sensyne Health (SENS) Share Price, News & Analysis

Sensyne Health logo

About Sensyne Health Stock (LON:SENS)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
0.35
0.35
52-Week Range
N/A
Volume
4.45 million shs
Average Volume
3.45 million shs
Market Capitalization
£583,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.

Remove Ads
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

SENS Stock News Headlines

FBI Warns: Wave Of Retiree Cyber Hacks Coming In 2025
Try to think back to the fall of 2008… The pandemic accelerated America's descent into a “no-cash society” by several years…
Are Health Insurance Premiums Tax-Deductible?
Find The Right Health Insurance For You
See More Headlines

SENS Stock Analysis - Frequently Asked Questions

Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensyne Health investors own include bluebird bio (BLUE), BP (BP), Green Plains Partners (GPP), Royal Dutch Shell (RDSB), Artemis Resources (ARV), Athene (ATH) and BELLUS Health (BLU).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
LON:SENS
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.81 million
Price / Cash Flow
0.07
Book Value
GBX 20.30 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£583,000.00
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:SENS) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners